Downloading...
Download

Patent

4 takeaways from EmTech Digital's AI conferenceMIT Technology Review recently put on its EmTech Digital conference. It will come as no surprise that this year’s focus was generative artificial intelligence (AI). There is a sense that generative AI, in its many different forms, is important and that it will have an economic impact, but it’s not yet clear exactly how this will manifest itself in the coming years. Below we discuss the four key takeaways from the conference. 1. Changing how we interact with Microsoft Office Software It is well known that Microsoft has made significant investments in OpenAI and that there is a close relationship between the two firms—GPT-4 is accessible on certain Microsoft Azure service platforms, as an example. Microsoft had only just mentioned the import and expected impact of AI to its future business results as it reported on the period ended 31 March 2023, so we were curious what more they could add in a short presentation. However, Microsoft mentioned one of the most exciting things across the entire conference. We are all searching for ‘use cases’ and we are also all trying to figure out what it will look like to communicate with Office 365 software in ‘natural language’. Microsoft’s representative noted that he had seen an example case where there was a Word document, and that the technology was able to seamlessly interface with PowerPoint and to go from having a Word document to having a version expressed in slides. In WisdomTree’s research team, taking a source file in text form and converting it to a potential presentation is an important function; some situations require slides, some situations require emails, some situations require Word documents. It takes a really long time to laboriously change a Word document into relevant, impactful slides. If there was a way for the file in Word to communicate with PowerPoint to create at least a rough draft with slides, over the course of the year within WisdomTree’s research team alone this would save a rather large amount of team hours. Since it probably could also work in reverse (PowerPoint back to Word), maybe we are not far away from drafts of blog posts being created off of PowerPoint slides. 2. Did you realise that AI cannot hold a patent? Part of what is sparking the current generative AI revolution has to do with creation. People are excited for the capability to create images, molecules, text, to name just a few things. However, the world is seeking to get a better handle on the legal ramifications. One such example regards Stability AI’s image generation capability. Getty Images, a major holder of rights to photographic content, has alleged that the use of their images in this way runs afoul of its licensing provisions, and that their images are quite valuable for training purposes due to diversity of subject matter and detailed metadata1. The value of access to training data, therefore, is coming to light. Another thing we did not realise was that, if AI is involved in the creation of something novel, AI cannot hold a patent, which could have interesting intellectual property implications in the US. An article in the National Law Review, published on 2 May 2023, affirmed that “Federal Circuit Holds That AI Cannot Be an “Inventor” Under the Patent Act - Only Humans Can Get Patents2.” 3. The magic of defect detection One of the most exciting presentations, in our opinion, regarded ‘defect detection’ from the firm Landing AI. In recent years, we have spent a lot of time thinking about electric vehicles, and WisdomTree as a global business has many funds that focus on different metals, different types of companies—basically all sorts of ways that investors can align an investment with trends they are seeing. The world needs more batteries, that much is clear, but batteries need to be assembled in a way that limits defects. When people mention ‘computer vision’ by itself, without an application, it doesn’t always sound exciting or capture the imagination. Seeing the presentation immediately helped us to picture all of the new factories being built to assemble more battery cells, taking advantage of certain funding provisions in the Inflation Reduction Act in the United States. Picturing a computer vision system, deployed at scale, able to catch defective battery cells in close to real-time, could be immensely valuable. All manufacturing companies could benefit from better defect detection. It was interesting to hear in the presentation how there is so much money in things like ‘Targeted Advertising’ and ‘Internet Search’ that this is where a lot of AI applications are developed, but if a company can serve the totality of need across different manufacturing concerns, it could be a big market as well and immensely valuable if these systems can really catch defective products before they are shipped. It was also particularly powerful to watch a demonstration of how a company might have a series of pictures in a database and use AI to ‘learn’ to recognise a particular attribute, like a crack. This could deploy better defect detection at scale as well as putting model training in the hands of people without PhD’s in data science, both very impactful things. 4. The maths of drug development is prohibitive A few presentations during the event concerned drug discovery, and for good reason. It was mentioned that the development of a given molecule into a drug takes roughly $2 billion, 10 years and has a 96% failure rate along the way. While we need drug therapies, the statistical specification of that journey does not sound compelling, and it makes those drugs that get through extremely expensive. Whether it is Nvidia or Exscientia presenting, so far the critical element is not to say that ‘AI is creating drugs’ but rather ‘AI is improving our chances’. Chemistry and physics are much like languages and there are certain rules that govern how they work. Generative AI does not always craft finished prose, but it is able to put many options to the page quite quickly. Generative AI for drug development is most likely to help researchers make better, higher probability attempts at further study. One thing that was very notable to hear was that we might be at a transition point in how research is done. Human researchers seeking the cure or a new therapy for a particular disease converge quite closely around a lot of similar ideas. For approaches run by humans, this makes sense. But for approaches with machine learning closer to the forefront, there may not be enough diversity across the data from the attempts such that the machine learning algorithm can find notable relationships across the data that human researchers would have been less likely to see. If machine learning algorithms are closer to the forefront, it can change the way certain types of research, like drug discovery, are done such that the systems are getting the appropriate breadth of data from which to draw out patterns and relationships. Conclusion: 2023 as a turning point History is replete with turning points. eCommerce, internet search, smart phones, the app economy, social media—all of these things had a ‘beginning’ where success was far from assured and we could not have predicted exactly where the technologies would go. Even if AI has been developing for many years, maybe 2023 will be seen as somewhat of a beginning, in that it marked the point after which non-technical people were using AI just like it was any other application. Sources 1 Source: Brittain, Blake. “Getty Images lawsuit says Stability AI misused photos to train AI.” Reuters. February 6, 2023. 2 Source: “Federal Circuit Holds that AI Cannot Be an ‘Inventor’ Under the Patent Act—Only Humans Can Get Patents.” The National Law Review. May 6, 2023. Volume XIII, Number 126.
SPARKS:AIX
by aneekaguptaWTE
AQMS, next Highflyer like NIO Part 2In that second Part i will highlight the similarities between NIO and AQMS. Compare the two ellipses with each other and you can see how they are equal and see the steep increase Nio had. The increase from the low at 2.16 USD was 29.5 fold (!!!) up to the Top. Taking that into account for Aqua Metals would mean a Top around 36 USD. The fundamental drivers behind such a massive increase could be new contracts with their lead recycling patents, overgenerating income and a final solution for their ongoing research on Lithium-Ion battery recycling, especially with contracts in the car industry. As always only my Opinion and no trade advice. Referring to my last Chart on AQMS
NASDAQ:AQMSLong
by coinwide
1
AirPods To Gain Amazing Feature UpdateApple consistently improves the features in its suite of fitness monitoring. It adds new elements, like the recent Time to Run, for instance. But a newly revealed patent indicates it has plans to change things. I’m not sure I like it. The patent means it’s not going to be as easy to cheat when you’re working out. I can remember a visit to Apple’s secret research labs for Fitness+ and being told that a new yoga workout was being added to Apple Watch. It meant, I was told, that it would be much more accurate than the current version.
NASDAQ:AAPLLong
by suppretbicold
Aqua Metals, the next Highflyer like NIOAqua Metals had a superior run, after the Crash with the burned Lead refining factory they got lots of support from their insurance company to build up again and to come along with their patent system on their 99,99% lead recycling patent. Got contracts in India via Patent and now acquired a new company with their Patent to recycle Lithium batteries/akkus aswell. The prospected market outlook in the next 3 years is massive as more and more EV get on the streets and their batteries need to get recycled. The market is somewhere in the 25 Billions as i remember, will bring along detailled figures here. So far the fundametals are amazing, let's get over to the TA. AQMS made a pullback to the daily 21 EMA, which was the best entry if not invested already. So far we still can retest another Fibos lower around the 4.20 - 2.70 USD, true BUY-INNS. The daily Bullish cross on the MACD will bring us up very fast coming week or 2. Conclusion - Aqua Metals is a rising star with a unique selling point, their lead recycling and now adopting to get the lithium recycling aswell, which comes to 2 unique selling points ;) A clear growth Share. Trade safe and as always, this is just my own opinion and no trading advice. Yours coinwide
NASDAQ:AQMSLong
by coinwide
1
$PHUN Massive Mobile App Patent$PHUN Awarded huge mobile app patent Went $10-$500-$5 in 6 months and never had a R/S, reason for the massive spike is because most of the O/S is restricted and very little shares are actually freely tradable. So those prices are accurate which means it’s very possible to do at the least $15-$30 in a week or two. Sounds pumpy but I like the odds here. Float is around 3 mil or so also. Phunware granted US patent number 10,254,378 titled "Mobile device localization based on relative received signal strength indicators" finance.yahoo.com
NASDAQ:PHUNLong
by StockGuild
$BYOC Continues Uptrend on Very Strong Buying Volume EOD Friday***UPDATED #BYOC FULL DD PACKAGE*** DD by Dwayne: (1) Boustead, (2) APAI's Patent/IP, (3) Who else might get rolled into #BYOC, (4) NASDAQ beyondcommercedd.businesscatalyst.com byoc.businesscatalyst.com DD by Tripz: docs.google.com DD by Wishmaster NASDAQ IPO's: $BYOC inks a $10M Deal with Boustead Securities, LLC. Just one of their many: www.boustead1828.com ih.advfn.com On October 4, 2017, Beyond Commerce, Inc. a Nevada corporation retained Boustead Securities, LLC, a California limited liability company as the Company’s exclusive placement agent for a financing of up to $10 million via a private placement of the Company’s securities conducted pursuant to Regulation D 506(c) of the Securities Act of 1933 and as filed with the Securities and Exchange Commission in a transaction exempt from registration under the Securities Act of 1933, as amended, and in compliance with the applicable laws and regulations of any jurisdiction in which securities are sold. The Company will use the additional financing to continue expanding its global reach, accelerate product growth and innovation, and invest in additional sales and marketing resources.
OTC:BYOCLong
by StockGuild
$VCPS Wine Club and App Patent Approval Could Send This .01+***$VCPS GROUNDBREAKING WINE INDUSTRY APP LAUNCH*** VCPS is an OTC Pink stock that is current and trademarked in the wine industry with a mobile app; patent pending. The wine industry is expected to continue it’s exponential growth in 2017. VinCompass seems to have a leg up on this projection with the amount of effort they have put into their brand. Special Wine club The VinCompass Signature Series Wine Club is a key component of our members' ongoing wine journeys. Featured wines are true to their places of origin, but also demonstrate innovations in winemaking that make them must-haves for those interested in expanding their wine experiences. While not all the featured wines have cellaring potential, they will all bring delight to your table. VinCompass Currently has a Wine Club that will bring in substantial income a rundown of which follows: Wines $50 and under: 3 Per Month $90 Monthly Payment 6 Per Month $180 Monthly Payment 9 Per Month $270 Monthly Payment 12 Per Month $360 Monthly Payment Wines over $50 but under $100: 3 Per Month $180 Monthly Payment 6 Per Month $360 Monthly Payment 9 Per Month $540 Monthly Payment 12 Per Month $720 Monthly Payment Wines over $100: 3 Per Month $270 Monthly Payment 6 Per Month $540 Monthly Payment 9 Per Month $810 Monthly Payment 12 Per Month $1080 Monthly Payment VinCompass is a wine company that is working on a patent pending application similar to Leafly (marijuana) and Zillow (real estate) but for the wine Industry. Their application is downloadable on both the Android and Apple App Stores. Access to their application is currently by invitation only. Per their website you can request an invitation code via [email protected] (This is thought as a testing phase before the approval of their patent.) Their application is patent pending and has been projected to be granted in 2017. The company has been noticeably busy on OTCMarkets as of June 2017 and the CEO has even purchased 18 million company shares at a higher price than it was worth at the time per Form 5. It is thought that the patent may already be granted and they are getting their filings up to date and buying company stock before announcing anything.
VLong
by StockGuild
KIOR Beat downKIOR has a black eye that looks so bad, it seems to have hit every piece of furniture and stairs on its way down to the basement. Management has send the distress call that they need money now to keep the doors open. Most people would write the company off and let it bleed out. But.... There seems to be a little bit of gold buried deep down inside KIOR. Lets face it. No one likes Ethanol. Even thou this form of ethanol doesnt harm a single shred of corn. Cellulose Ethanol hasn't been well supported by the government and Oil hates it. However, the EPA has been taking a very very long time in reformulating the RFS and we think there may be some relief in store for companies like KIOR. If it can hang on of course. The only other thing KIOR has going for it is its PATENTS. www.faqs.org As you can see the company has a lot of them! Enough to change the valuation dynamics of the company. This is an all or nothing one way bet. A long here puts all capital at risk of instant bankruptcy death. Of course, should the stock rally, the pay of could be huge. Speculative long only.
KLong
by nysedaytraders1